Aci Worldwide [ACIW] vs Oracle [ORCL] Detailed Stock Comparison

Aci Worldwide
NASDAQ
Loading...

Oracle
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Aci Worldwide wins in 9 metrics, Oracle wins in 10 metrics, with 0 ties. Oracle appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Aci Worldwide | Oracle | Better |
---|---|---|---|
P/E Ratio (TTM) | 16.66 | 58.19 | Aci Worldwide |
Price-to-Book Ratio | 2.99 | 34.66 | Aci Worldwide |
Debt-to-Equity Ratio | 59.89 | 519.59 | Aci Worldwide |
PEG Ratio | 20.76 | 35.27 | Aci Worldwide |
EV/EBITDA | 12.58 | 34.39 | Aci Worldwide |
Profit Margin (TTM) | 16.13% | 21.68% | Oracle |
Operating Margin (TTM) | 14.83% | 32.48% | Oracle |
EBITDA Margin (TTM) | 14.83% | 32.48% | Oracle |
Return on Equity | 19.69% | 82.38% | Oracle |
Return on Assets (TTM) | 7.00% | 7.26% | Oracle |
Free Cash Flow (TTM) | $313.70M | $-394.00M | Aci Worldwide |
Dividend Yield | N/A | 0.81% | N/A |
1-Year Return | -6.05% | 94.18% | Oracle |
Price-to-Sales Ratio (TTM) | 2.64 | 12.36 | Aci Worldwide |
Enterprise Value | $5.08B | $807.58B | Oracle |
EV/Revenue Ratio | 3.04 | 14.07 | Aci Worldwide |
Gross Profit Margin (TTM) | 45.92% | 70.19% | Oracle |
Revenue per Share (TTM) | $16 | $21 | Oracle |
Earnings per Share (Diluted) | $2.53 | $4.34 | Oracle |
Beta (Stock Volatility) | 1.08 | 1.43 | Aci Worldwide |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Aci Worldwide vs Oracle Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Aci Worldwide | 1.85% | 2.77% | -3.80% | -20.30% | -17.30% | -16.83% |
Oracle | 0.28% | -1.73% | 7.38% | 66.96% | 42.95% | 50.21% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Aci Worldwide | -6.05% | 67.51% | 42.62% | 90.06% | 559.19% | 407.77% |
Oracle | 94.18% | 223.98% | 373.12% | 550.67% | 1,031.64% | 1,828.05% |
Performance & Financial Health Analysis: Aci Worldwide vs Oracle
Metric | ACIW | ORCL |
---|---|---|
Market Information | ||
Market Cap | $4.42B | $709.31B |
Market Cap Category | Mid cap | Mega cap |
10 Day Avg. Volume | 924,720 | 9,447,430 |
90 Day Avg. Volume | 745,460 | 13,061,150 |
Last Close | $44.55 | $250.10 |
52 Week Range | $40.45 - $59.71 | $118.86 - $260.87 |
% from 52W High | -25.39% | -4.13% |
All-Time High | $59.71 (Nov 25, 2024) | $260.87 (Jul 31, 2025) |
% from All-Time High | -25.39% | -4.13% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.25% | 0.11% |
Quarterly Earnings Growth | 0.25% | 0.09% |
Financial Health | ||
Profit Margin (TTM) | 0.16% | 0.22% |
Operating Margin (TTM) | 0.15% | 0.32% |
Return on Equity (TTM) | 0.20% | 0.82% |
Debt to Equity (MRQ) | 59.89 | 519.59 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $14.08 | $7.29 |
Cash per Share (MRQ) | $2.19 | $3.99 |
Operating Cash Flow (TTM) | $313.73M | $20.82B |
Levered Free Cash Flow (TTM) | $306.69M | $678.00M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 0.81% |
Last 12-Month Dividend | N/A | $1.70 |
Valuation & Enterprise Metrics Analysis: Aci Worldwide vs Oracle
Metric | ACIW | ORCL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 16.66 | 58.19 |
Forward P/E | 20.76 | 35.27 |
PEG Ratio | 20.76 | 35.27 |
Price to Sales (TTM) | 2.64 | 12.36 |
Price to Book (MRQ) | 2.99 | 34.66 |
Market Capitalization | ||
Market Capitalization | $4.42B | $709.31B |
Enterprise Value | $5.08B | $807.58B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 3.04 | 14.07 |
Enterprise to EBITDA | 12.58 | 34.39 |
Risk & Other Metrics | ||
Beta | 1.08 | 1.43 |
Book Value per Share (MRQ) | $14.08 | $7.29 |
Financial Statements Comparison: Aci Worldwide vs Oracle
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ACIW | ORCL |
---|---|---|
Revenue/Sales | $394.57M | $15.90B |
Cost of Goods Sold | $213.38M | $4.74B |
Gross Profit | $181.19M | $11.16B |
Research & Development | $38.91M | $2.65B |
Operating Income (EBIT) | $58.52M | $5.19B |
EBITDA | $112.74M | $7.00B |
Pre-Tax Income | $71.64M | $4.15B |
Income Tax | $12.77M | $725.00M |
Net Income (Profit) | $58.87M | $3.43B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ACIW | ORCL |
---|---|---|
Cash & Equivalents | $230.06M | $10.79B |
Total Current Assets | $1.21B | $24.58B |
Total Current Liabilities | $804.51M | $32.64B |
Long-Term Debt | $831.84M | $96.83B |
Total Shareholders Equity | $1.48B | $20.97B |
Retained Earnings | $1.66B | $-15.48B |
Property, Plant & Equipment | $60.17M | $0 |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ACIW | ORCL |
---|---|---|
Operating Cash Flow | $129.33M | $5.93B |
Capital Expenditures | $-2.17M | N/A |
Free Cash Flow | $69.29M | $-2.92B |
Debt Repayment | $-83.59M | $-6.07B |
Common Stock Repurchase | $-14.41M | $-150.00M |
Short Interest & Institutional Ownership Analysis
Metric | ACIW | ORCL |
---|---|---|
Shares Short | 2.66M | 20.68M |
Short Ratio | 4.10 | 1.27 |
Short % of Float | 0.04% | 0.01% |
Average Daily Volume (10 Day) | 924,720 | 9,447,430 |
Average Daily Volume (90 Day) | 745,460 | 13,061,150 |
Shares Outstanding | 105.25M | 2.81B |
Float Shares | 103.78M | 1.64B |
% Held by Insiders | 0.01% | 0.42% |
% Held by Institutions | 1.00% | 0.45% |
Dividend Analysis & Yield Comparison: Aci Worldwide vs Oracle
Metric | ACIW | ORCL |
---|---|---|
Last 12-Month Dividend | N/A | $1.70 |
Last 12-Month Dividend Yield | N/A | 0.81% |
3-Year Avg Annual Dividend | N/A | $1.55 |
3-Year Avg Dividend Yield | N/A | 0.36% |
3-Year Total Dividends | N/A | $4.66 |
Ex-Dividend Date | N/A | Apr 10, 2025 |